Mucormycosis: Issues, Pathophysiology, Diagnosis and Treatment
DOI:
https://doi.org/10.61814/jkahs.v6i1.521Keywords:
mucormycosis, immuno-compromised, amphotericin B, Rhino-orbitalAbstract
Mucormycosis (Black fungus) is an infection caused by opportunistic fungi of order Mucorales affecting the immune-compromised individuals. Cases of Aspergillus and Candida (White fungus) were also reported. The cases of fungal co-infection in COVID-19 patients are increasing globally affecting mainly diabetic patients and individuals that have undergone corticosteroid therapy. Iron metabolism and hypoxia plays an important role in pathophysiology of this disease. Mucormycosis causes thrombosis of blood vessels hindering the blood circulation causing black discoloration of affected site. Histopathological examination of specimen is the most effective way of its diagnosis. Surgical removal of affected site is the best treatment practice in rhino-orbital and cutaneous cases whereas lipid formulation of Amphotericin B is effective in other forms of fungal infection.
References
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. [Google scholar]
Baker RD. Mucormycosis Mucormycosis Intestinal mucormycosis presents as hemorrhagic Organism .— Rhizopus ,. Published online 2015:1954-1957. DOI: 10.1001/jama.1957.02970450007003 [PubMed]
Estados Unidos. Center for Diseases Control and Prevention (CDC). Mucormycosis : The Basics. Published online 2011:2011. [Full text]
Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clinical Infectious Diseases. 2005;41(5):634-653.[Google Scholar]
Bouza E, Muñoz P, Guinea J. Mucormycosis: An emerging disease? Clinical Microbiology and Infection. 2006;12(SUPPL. 7):7-23. doi:10.1111/j.1469-0691.2006.01604.x [Google Scholar]
Kwon-Chung KJ, Sugui JA. Aspergillus fumigatus—what makes the species a ubiquitous human fungal pathogen? PLoS Pathog. 2013;9(12):e1003743. [PubMed]
Tsang CC, Tang JYM, Lau SKP, Woo PCY. Taxonomy and evolution of Aspergillus, Penicillium and Talaromyces in the omics era – Past, present and future. Comput Struct Biotechnol J. 2018;16:197-210. doi: 10.1016/j.csbj.2018.05.003 [Google Scholar]
McGinnis MR, Ajello L, Beneke ES, et al. Taxonomic and nomenclatural evaluation of the genera Candida and Torulopsis. J Clin Microbiol. 1984;20(4):813-814. doi:10.1128/jcm.20.4.813-814.1984 [Google Scholar]
Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. Journal of Fungi. 2019;5(1):26. [PMC]
Chander J, Kaur M, Singla N, et al. Mucormycosis: battle with the deadly enemy over a five-year period in India. Journal of Fungi. 2018;4(2):46. [Google Scholar]
Chakrabarti A, Dhaliwal M. Epidemiology of mucormycosis in India. Curr Fungal Infect Rep. 2013;7(4):287-292.[Google Scholar]
Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clinical Microbiology and Infection. 2019;25(1):26-34. [Google Scholar]
Chakrabarti A, Das A, Sharma A, et al. Ten years’ experience in zygomycosis at a tertiary care centre in India. Journal of Infection. 2001;42(4):261-266. [Google Scholar]
Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clinical Microbiology and Infection. 2011;17(12):1859-1867. [Google Scholar]
Holzel H, Macqueen S, MacDonald A, et al. Rhizopus microsporus in wooden tongue depressors: a major threat or minor inconvenience? Journal of Hospital Infection. 1998;38(2):113-118. [Google Scholar]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020;395(10223):507-513. [Full Text]
Koehler P, Cornely OA, Böttiger BW, et al. COVID‐19 associated pulmonary aspergillosis. Mycoses. 2020;63(6):528-534. [PubMed]
van Arkel ALE, Rijpstra TA, Belderbos HNA, Van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19–associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020;202(1):132-135. [PubMed]
Kwon-Chung KJ, Bennett JE. Medical mycology. Rev Inst Med Trop Sao Paulo. 1992;34(6):504. [Google Scholar]
Yang W, Cao Q, Qin LE, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. Journal of Infection. 2020;80(4):388-393. [Google Scholar]
Group RC. Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine. 2021;384(8):693-704. [Full Text]
Ibrahim AS, Edwards JEJ, Filler SG. Zygomycosis. 241–251. Clinical mycology Oxford University Press, New York, NY. Published online 2003. [PMC]
Guinea J, Escribano P, Vena A, et al. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. PLoS One. 2017;12(6):e0179136. [Full Text]
Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DP. A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. Journal of Infection. 2009;59(2):134-138. [Google Scholar]
Howard DH. Acquisition, transport, and storage of iron by pathogenic fungi. Clin Microbiol Rev. 1999;12(3):394-404. [Google Scholar]
Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis transferrin and iron availability. Diabetes. 1982;31(12):1109-1114. [Google Scholar]
Ibrahim A, Spellberg B, Edwards Jr J. Iron Acquisition: a novel prospective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008;21(6):620. [Google Scholar]
Boelaert JR, de Locht M, Van Cutsem J, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest. 1993;91(5):1979-1986. [Google Scholar]
Van Cutsem J, Boelaert JR. Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). Kidney Int. 1989;36(6):1061-1068. [Google Scholar]
Liu M, Spellberg B, Phan QT, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010;120(6):1914-1924. [Google Scholar]
Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009;15(9):1395. [PMC]
Castaldo P, Stratta RJ, Wood RP, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Archives of Surgery. 1991;126(2):149-156. [PubMed]
Da Nam B, Kim TJ, Lee KS, Kim TS, Han J, Chung MJ. Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings. Eur Radiol. 2018;28(2):788-795. [PubMed]
Hammer MM, Madan R, Hatabu H. Pulmonary mucormycosis: radiologic features at presentation and over time. American Journal of Roentgenology. 2018;210(4):742-747. [Google Scholar]
Singla K, Samra T, Bhatia N. Primary cutaneous mucormycosis in a trauma patient with Morel-Lavallee lesion. Indian J Crit Care Med. 2018;22(5):375. [PubMed]
Al-Tarrah K, Abdelaty M, Behbahani A, Mokaddas E, Soliman H, Albader A. Cutaneous mucormycosis postcosmetic surgery: a case report and review of the literature. Medicine. 2016;95(27). [Google Scholar]
Roilides E, Zaoutis TE, Katragkou A, Benjamin Jr DK, Walsh TJ. Zygomycosis in neonates: an uncommon but life-threatening infection. Am J Perinatol. 2009;26(8):565. [Google Scholar]
Fong KM, Seneviratne EME, McCormack JG. Mucor cerebral abscess associated with intravenous drug abuse. Aust N Z J Med. 1990;20(1):74-77. [PubMed]
McAdams HP, Rosado de Christenson M, Strollo DC, Patz Jr EF. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol. 1997;168(6):1541-1548. [PubMed]
Petrikkos G, Skiada A, Sambatakou H, et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. European Journal of Clinical Microbiology and Infectious Diseases. 2003;22(12):753-756. [Google Scholar]
Stamm B. Mucormycosis of the stomach in a patient with multiple trauma. Histopathology. 2005;47(2):222-223. [PubMed]
Teggi A, Fedele A, Bagnato R, Traditi F, Lanzalone CM, De Rosa F. A case of disseminated mucormycosis. Recenti Prog Med. 1989;80(6):308-313. [Google Scholar]
Nosari A, Oreste P, Montillo M, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica. 2000;85(10):1068-1071. [Google Scholar]
Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KVI. Zygomycosis in the 1990s in a tertiary-care cancer center. Clinical Infectious Diseases. 2000;30(6):851-856. [PubMed]
Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-e421. doi:10.1016/S1473-3099(19)30312-3 [PubMed]
Sheth CC, Johnson E, Baker ME, Haynes K, Mühlschlegel FA. Phenotypic identification of Candida albicans by growth on chocolate agar. Med Mycol. 2005;43(8):735-738. doi:10.1080/13693780500265998 [Google Scholar]
Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infectious Diseases. 2005;5(10):609-622. doi:10.1016/S1473-3099(05)70238-3 [Google Scholar]
Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 2001;125(3):375-378. [Google Scholar]
Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral Mucormycosis : Evolution of the Disease and Treatment Options. 1997;(July). [Google Scholar]
Factors S, Mucormycosis R orbital cerebral. MAJOR REVIEW Survival Factors in Rhino-Orbital-Cerebral. 1994;39(1). DOI: 10.1016/s0039-6257(05)80041-4 [PubMed]
Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent Advances in the Management of Mucormycosis : From Bench to Bedside. 2009;48(table 1). doi:10.1086/599105 [Google Scholar]
Barron MA, Lay M, Madinger NE. Surgery and Treatment with High-Dose Liposomal Amphotericin B for Eradication of Craniofacial Zygomycosis in a Patient with Hodgkin ’ s Disease Who Had Undergone Allogeneic Hematopoietic Stem Cell Transplantation. 2014;43(4):2012-2014. doi:10.1128/JCM.43.4.2012 [Google Scholar]
Sun QN, Fothergill AW, Mccarthy DI, et al. In Vitro Activities of Posaconazole , Itraconazole , Voriconazole , Amphotericin B , and Fluconazole against 37 Clinical Isolates of Zygomycetes In Vitro Activities of Posaconazole , Itraconazole , Voriconazole , Amphotericin B , and Fluconazole against 3. Published online 2002:1581-1583. doi:10.1128/AAC.46.5.1581 [PMC]
Sabatelli F, Patel R, Mann PA, et al. In Vitro Activities of Posaconazole , Fluconazole , Itraconazole , Voriconazole , and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts. 2015;50(6):2009-2015. doi:10.1128/AAC.00163-06 [Google Scholar]
Dannaoui E, Meis JFGM, Loebenberg D, Verweij PE. Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis. 2003;47(11):3647-3650. doi:10.1128/AAC.47.11.3647 [Google Scholar]
Ibrahim AS, Spellberg B, Edwards J. Iron acquisition : a novel perspective on mucormycosis pathogenesis and treatment. Published online 2016. doi:10.1097/QCO.0b013e3283165fd1 [Google Scholar]
Mignogna MD, Fortuna G, Leuci S, et al. International Journal of Infectious Diseases Mucormycosis in immunocompetent patients : a case-series of patients with maxillary sinus involvement and a critical review of the literature. International Journal of Infectious Diseases. 2011;15(8):e533-e540. doi:10.1016/j.ijid.2011.02.005 [PubMed]
Fungus B, Unfortunately AB. The outbreak of mucormycosis ( the so- called “ Black Fungus ”) in India is a prime example of the great need for a safer antifungal drug with true fungicidal activity. Published online 2021.
Nehara HR, Puri I, Singhal V, IH S, Bishnoi BR, Sirohi P. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India. Indian J Med Microbiol. 2021;(December 2020). doi:10.1016/j.ijmmb.2021.05.009 [PubMed]
Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021;42:264-e5. [Google Scholar]
Nehara HR, Puri I, Singhal V, IH S, Bishnoi BR, Sirohi P. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India. Indian J Med Microbiol. 2021;(December 2020). doi:10.1016/j.ijmmb.2021.05.009 [Google Scholar]
Nasir N, Farooqi J, Mahmood SF, Jabeen K. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan. Mycoses. 2020;63(8):766-770. doi:10.1111/myc.13135 [PubMed]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sagar Regmi, Prem
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).
Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).
More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below: https://creativecommons.org/licenses/by/4.0/
